https://www.selleckchem.com/pr....oducts/AR-42-HDAC-42
ve shown that most patients were on sacubitril/valsartan 97/103 mg b.i.d. and the treatment was well tolerated. The patient-reported outcomes showed an overall improvement in patients' QoL. We set out to compare in a prospective cohort study the mid-term clinical and echocardiographic outcomes of mini-mitral repair for simple (posterior prolapse) vs complex regurgitation (anterior/bileaflet prolapse). A total of 245 consecutive patients underwent mini-mitral repair for severe degenerative mitral regurgitation through a right, endo
Gefällt mir
Kommentar
Teilen
